This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$32.24
US$ Class I Dist
NAV per share 02.07.2020
£560.7mAUM

AUM 29.05.2020

Holdings
67.12% Active Share
As at 29.05.2020